- ICH GCP
- US Clinical Trials Registry
- Search trials
Clinical Trials on Leukemia Relapse in France
Total 1181 results
-
Hospices Civils de LyonCompletedAcute Leukaemia in RelapseFrance
-
Institut Paoli-CalmettesINATHERYSRecruitingAcute Lymphoblastic Leukemia, in Relapse | Acute Myeloid Leukemia, in Relapse | Mixed Phenotype Acute Leukemia | Acute Lymphoblastic Leukemia Recurrent | Acute Myeloid Leukaemia RecurrentFrance
-
University Hospital, LilleAssistance Publique - Hôpitaux de Paris; Hospices Civils de Lyon; Central Hospital... and other collaboratorsCompletedAcute Lymphoid Leukemia Relapse | Acute Lymphoid Leukemia Relapse After Bone Marrow TransplantFrance
-
Group for Research in Adult Acute Lymphoblastic...AmgenUnknownAcute Lymphoblastic Leukemia, in Relapse | Acute Lymphoblastic Leukemia With Failed RemissionFrance
-
University Hospital, Strasbourg, FranceUnknown
-
Aptose Biosciences Inc.TerminatedAcute Myelogenous Leukemia | Acute Myelogenous Leukemia in Relapse | Acute Myelogenous Leukemia, Relapsed, Adult | Acute Myelogenous Leukemia, Adult | High Risk MyelodysplasiaUnited States
-
University Hospital, AngersTerminatedB Acute Lymphoblastic Leukemia | Leukemia RelapseFrance
-
Advesya SASNot yet recruitingAcute Myeloid Leukemia, in Relapse | Acute Myeloid Leukemia RefractoryFrance, Sweden, Spain, Germany
-
University Hospital, ToulouseRecruitingRelapsed or Refractory Acute Myeloid LeukemiaFrance
-
ERYtech PharmaCentre Leon BerardCompletedAcute Lymphoblastic LeukemiaFrance
-
Rennes University HospitalLigue contre le cancer, FranceCompletedAcute Lymphoblastic Leukemia (ALL)France
-
Institut de Recherches Internationales ServierADIR, a Servier Group companyCompletedRelapsed or Refractory Multiple Myeloma | Relapsed or Refractory Acute Myeloid Leukemia | Relapsed or Refractory Non-Hodgkin Lymphoma | Relapsed or Refractory Chronic Lymphocytic LeukemiaUnited Kingdom, Spain, France, Australia
-
ERYtech PharmaCompletedAcute Lymphoblastic Leukemia, in RelapseFrance, Belgium
-
Mundipharma Research LimitedInnovative Therapies For Children with Cancer ConsortiumTerminatedRelapsed or Refractory T-cell Acute Lymphoblastic Leukaemia | B-cell Precursor Acute Lymphoblastic Leukaemia | T-cell Non-Hodgkin's LymphomaCzech Republic, Austria, France, Germany, Italy, United Kingdom
-
Hospices Civils de LyonCompleted
-
Institut CurieNational Cancer Institute, France; Fondation ARCTerminatedAcute Myeloid Leukemia, in Relapse | Therapy-related Acute Myeloid Leukemia and Myelodysplastic Syndrome | de Novo Acute Myeloid Leukemia at DiagnosticFrance
-
Assistance Publique - Hôpitaux de ParisRecruitingAcute Lymphoblastic Leukemia, in Relapse | B Acute Lymphoblastic LeukemiaFrance
-
Menarini GroupTerminatedRecurrent Adult Acute Myeloid Leukemia | Acute Myeloid Leukemia, in RelapseFrance, Germany, Italy, Spain, Belgium
-
Nantes University HospitalTerminatedRelapsed/Refractory LeukemiaFrance
-
Cornerstone PharmaceuticalsTerminatedRelapsed/Refractory Acute Myeloid LeukemiaUnited States, Spain, Korea, Republic of, France, Australia, Belgium, Austria, Germany, Poland
-
University Hospital, BordeauxCompletedLeukemia, Myelogenous, Chronic, BCR-ABL PositiveFrance
-
University of California, IrvineTerminated
-
University Hospital, BrestRecruitingChronic Lymphoid LeukaemiaFrance
-
Therapeutic Advances in Childhood Leukemia ConsortiumGlaxoSmithKline; NovartisTerminatedRelapsed T-Cell Acute Lymphoblastic Leukemia | Relapsed T-Cell Lymphoblastic LymphomaUnited States, France, Canada, Australia, Austria, Italy, Netherlands
-
French Innovative Leukemia OrganisationAcute Leukemia French AssociationRecruitingAML, Adult | Relapsed Adult AML | Refractory AML | FLT3-TKD Mutation | FLT3-ITDFrance
-
AstraZenecaTerminatedRelapsed or Refractory Acute Myeloid Leukemia (AML)United States
-
Jazz PharmaceuticalsThe Leukemia and Lymphoma SocietyCompletedAcute Myeloid LeukemiaUnited States, Poland, Canada, France
-
University Hospital, Strasbourg, FranceUnknown
-
French Innovative Leukemia OrganisationBristol-Myers SquibbCompletedSmall Lymphocytic Leukemia | CLL, Relapsed | CLL, Refractory | Bruton Tyrosine Kinase InhibitorFrance
-
Therapeutic Advances in Childhood Leukemia ConsortiumCompletedAcute Myelogenous LeukemiaUnited States, Canada, Australia
-
Institut de Recherches Internationales ServierADIR, a Servier Group companyCompletedAcute Myeloid LeukaemiaFrance, United States, Australia
-
AB ScienceRecruitingAcute Myeloid Leukemia, in Relapse | Acute Myeloid Leukemia Refractory | Myelodysplastic Syndrome Acute Myeloid LeukemiaUnited States, Spain, France, Greece
-
Molecular Partners AGRecruitingLeukemia | Acute | Relapsed | MyeloidNetherlands, France, Lithuania, Switzerland
-
Institut de Recherches Internationales ServierADIR, a Servier Group companyCompletedRefractory B-cell Acute Lymphoblastic Leukemia | Relapsed B-cell Acute Lymphoblastic LeukemiaUnited States, France, Spain, United Kingdom
-
Kite, A Gilead CompanyActive, not recruitingRelapsed/Refractory B-precursor Acute Lymphoblastic Leukemia | Relapsed/Refractory B-Cell Non-Hodgkin LymphomaSpain, United States, Czechia, Sweden, Germany, Belgium, Italy, Canada, France, Netherlands, Poland
-
French Innovative Leukemia OrganisationAcute Leukemia French AssociationCompletedRelapsed Adult AML | Refractory AML | FLT3-TKD Mutation | FLT3-ITDFrance
-
Kite, A Gilead CompanyCompletedRelapsed/Refractory B-precursor Acute Lymphoblastic LeukemiaUnited States, France, Germany, Netherlands, Canada
-
Assistance Publique - Hôpitaux de ParisCompletedMyelodysplastic Syndrome (MDS) | Acute Myelogenous Leukaemia (AML)France
-
Arog Pharmaceuticals, Inc.RecruitingRelapsed/Refractory Acute Myeloid Leukemia With FLT3 Activating MutationsUnited States, Germany, Spain, Italy, France, Canada
-
Institut de Recherches Internationales ServierADIR, a Servier Group companyCompletedAcute Myeloid LeukaemiaUnited States, Australia, France, Spain
-
Centre Hospitalier Henri LaboritRecruiting
-
Amsterdam UMC, location VUmcOdense University Hospital; Helsinki University Central Hospital; Aarhus University... and other collaboratorsRecruitingCML, RelapsedDenmark, Norway, Sweden, Netherlands, Finland, France, Germany
-
SanofiTerminated
-
French Innovative Leukemia OrganisationJanssen, LPActive, not recruitingRelapsed or Refractory Chronic Lymphocytic LeukemiaFrance
-
University Hospital, Clermont-FerrandRecruitingChronic Lymphocytic Leukemia | Refractory Chronic Lymphocytic Leukemia | CLL | Relapsed Chronic Lymphocytic Leukemia | Progressive Chronic Lymphocytic LeukemiaFrance
-
University of California, IrvineUnited States Department of DefenseActive, not recruitingAcute Myeloid Leukemia | Chronic Lymphocytic Leukemia | AML, Adult | CLL | CLL, Relapsed | CLL, RefractoryUnited States
-
Versailles HospitalRecruitingT-cell Acute Lymphoblastic Leukemia | Relapsed/Refractory Acute Lymphoblastic LeukemiaFrance
-
AmgenNo longer availableRelapsed/Refractory B-Precursor Acute Lymphoblastic LeukemiaUnited States, Italy, Germany, Austria, France, Switzerland, United Kingdom
-
Centre Hospitalier Universitaire de Saint EtienneTerminatedAllograft | Post-allograft RelapseFrance
-
Gilead SciencesOno Pharmaceutical Co. LtdCompletedChronic Lymphocytic Leukaemia | Non Hodgkins LymphomaUnited Kingdom, France